ThinkSono Guidance revolutionizes the way healthcare professionals approach Deep Vein Thrombosis (DVT) diagnosis. By leveraging artificial intelligence, this innovative tool guides users through compression ultrasound examinations, making it accessible for non-ultrasound trained professionals to collect crucial data for qualified clinicians to review. This not only streamlines the clinical pathway but also significantly reduces the time patients wait for test results, potentially saving lives by preventing pulmonary embolism (PE), a fatal condition that can arise from DVT.
Deep Vein Thrombosis is a serious condition where a blood clot forms in the deep veins of the leg. If parts of the clot break off and travel to the lungs, it can cause a pulmonary embolism, which is the leading cause of preventable hospital deaths. The current diagnostic process for DVT is often slow and inefficient, leading to delays in treatment. ThinkSono Guidance addresses this issue by enabling healthcare professionals to perform DVT exams in less than 15 minutes using only a compatible handheld device and a mobile phone.
The process is straightforward: conduct a compression ultrasound DVT exam with live AI guidance, upload the data, and receive a report. This intuitive system identifies the correct anatomy and probe positioning, allowing for fast and accurate data collection without the need for direct oversight. ThinkSono Guidance is particularly beneficial in emergency rooms, where it can reduce the burden on specialist sonographers by enabling staff to scan patients upon arrival and send the captured images and clips for review.
In the UK, ThinkSono's technology is being integrated into a redesigned community DVT pathway, allowing for rapid assessment in primary care settings. This means patients can be scanned locally by their GP without the need for specialist equipment, eliminating the need to travel to a hospital or book multiple appointments. Additionally, ThinkSono Guidance is being used on medical wards to assess patients for DVT, potentially eliminating the need to transfer complex patients to the ultrasound service.
ThinkSono Guidance has received CE Class IIb regulatory approval for clinical use in the EU and UK, with FDA clearance pending in the U.S. This approval underscores the tool's effectiveness and safety in improving the clinical pathway for DVT diagnosis. For healthcare professionals looking to enhance their diagnostic capabilities and improve patient outcomes, ThinkSono Guidance offers a cutting-edge solution powered by artificial intelligence.
